4536 — SANTEN PHARMACEUTICAL Share News
0.000.00%
Last trade - 00:00- ¥558bn
- ¥537bn
- ¥292bn
Table: Santen Pharm -Q1 group results (IFRS)
Table: Santen Pharm -2025/26 parent results
Table: Santen Pharm -2025/26 group results (IFRS)
Table: Santen Pharm -9-MTH group results (IFRS)
To Cancel 19,800,000 Shares
Table: Santen Pharm 6-MTH group results (IFRS)
Brief: Silchester International Raises Stake In Santen Pharmaceutical To 9.23% From 8.21%, Filing Shows
Brief: Silchester International Raises Stake In Santen Pharmaceutical To 8.21% From 7.13%, Filing Shows
RemeGen's HK shares climb to 3-1/2-year high on Santen's licence deal
Table: Santen Pharm -Q1 group results (IFRS)
To Buy Back Up To 5.8% Of Own Shares Worth 35 Billion Yen
Table: Santen Pharm -2024/25 group results (IFRS)
Table: Santen Pharm -2024/25 parent results
Brief: Silchester Raises Stake In Santen Pharmaceutical To 7.10% From 6.08% - Regulatory Filing
Brief: Silchester Raises Stake In Santen Pharmaceutical To 6.08% From 5.02%, Filing Shows
To Retire Treasury Shares Worth 1.4% Of Outstanding Stock On Feb 28
Table: Santen Pharm -9-MTH group results (IFRS)
To Buy Back Up To 1.4% Own Shares Worth 10 Billion Yen
To Retire Treasury Shares Worth 4.7% Of Outstanding Stock On Nov 29